Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients.

MLA

Hirzel, Cedric, et al. “Safety and Immunogenicity of Adjuvanted Recombinant Subunit Herpes Zoster Vaccine in Lung Transplant Recipients.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 21, no. 6, June 2021, pp. 2246–53. EBSCOhost, https://doi.org/10.1111/ajt.16534.

APA

Hirzel, C., L’Huillier, A. G., Ferreira, V. H., Marinelli, T., Ku, T., Ierullo, M., Miao, C., Schmid, D. S., Juvet, S., Humar, A., & Kumar, D. (2021). Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21(6), 2246–2253. https://doi.org/10.1111/ajt.16534

Chicago

Hirzel, Cedric, Arnaud G L’Huillier, Victor H Ferreira, Tina Marinelli, Terrance Ku, Matthew Ierullo, Congrong Miao, et al. 2021. “Safety and Immunogenicity of Adjuvanted Recombinant Subunit Herpes Zoster Vaccine in Lung Transplant Recipients.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (6): 2246–53. doi:10.1111/ajt.16534.